132 related articles for article (PubMed ID: 16275089)
1. Design, synthesis, and anti-Helicobacter pylori activity of erythromycin A (E)-9-oxime ether derivatives.
Nam G; Kang TW; Shin JH; Choi KI
Bioorg Med Chem Lett; 2006 Feb; 16(3):569-72. PubMed ID: 16275089
[TBL] [Abstract][Full Text] [Related]
2. Effects of anti-ulcer agents on antibiotic activity against Helicobacter pylori.
Sunairi M; Watanabe K; Suzuki T; Tanaka N; Kuwayama H; Nakajima M
Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S121-4. PubMed ID: 7735928
[TBL] [Abstract][Full Text] [Related]
3. Reality and false premises of antimicrobial susceptibility testing for Helicobacter pylori.
Miwa H; Sato N
J Gastroenterol; 2003; 38(5):519-21. PubMed ID: 12768400
[No Abstract] [Full Text] [Related]
4. [Synthesis and antibacterial activity of 3-hydroxy-6-O-methylerythromycin-9-O-substituted oxime derivatives].
Chen SX; Xu XD; Yu LX
Yao Xue Xue Bao; 2001 Aug; 36(8):581-4. PubMed ID: 12579933
[TBL] [Abstract][Full Text] [Related]
5. Structure-activity relationship of 2-[[(2-pyridyl)methyl]thio]-1H- benzimidazoles as anti Helicobacter pylori agents in vitro and evaluation of their in vivo efficacy.
Kühler TC; Swanson M; Shcherbuchin V; Larsson H; Mellgârd B; Sjöström JE
J Med Chem; 1998 May; 41(11):1777-88. PubMed ID: 9599229
[TBL] [Abstract][Full Text] [Related]
6. Studies on macrolide antibiotics I. Synthesis and antibacterial activity of erythromycin A 9-O-substituted oxime ether derivatives against Mycobacterium avium complex.
Nishimoto A; Narita K; Ohmoto S; Takahashi Y; Yoshizumi S; Yoshida T; Kado N; Okezaki E; Kato H
Chem Pharm Bull (Tokyo); 2001 Sep; 49(9):1120-7. PubMed ID: 11558597
[TBL] [Abstract][Full Text] [Related]
7. Comparative efficacy of new investigational agents against Helicobacter pylori.
Osato MS; Reddy SG; Piergies AA; Bochenek WJ; Testa RT; Graham DY
Aliment Pharmacol Ther; 2001 Apr; 15(4):487-92. PubMed ID: 11284777
[TBL] [Abstract][Full Text] [Related]
8. Effect of pH variation on the susceptibility of Helicobacter pylori to three macrolide antimicrobial agents and temafloxacin.
Malanoski GJ; Eliopoulos GM; Ferraro MJ; Moellering RC
Eur J Clin Microbiol Infect Dis; 1993 Feb; 12(2):131-3. PubMed ID: 8388791
[TBL] [Abstract][Full Text] [Related]
9. Anti-Helicobacter pylori agents. 1. 2-(Alkylguanidino)-4-furylthiazoles and related compounds.
Katsura Y; Tomishi T; Inoue Y; Sakane K; Matsumoto Y; Ishikawa H; Takasugi H
J Med Chem; 1997 Aug; 40(16):2462-5. PubMed ID: 9258352
[TBL] [Abstract][Full Text] [Related]
10. Erythromycin A oxime 11,12-carbonate and its oxime ethers.
Brain EG; Forrest AK; Hunt E; Shillingford C; Wilson JM
J Antibiot (Tokyo); 1989 Dec; 42(12):1817-22. PubMed ID: 2621163
[TBL] [Abstract][Full Text] [Related]
11. Beta-lactam antibiotics functionalized with gem-bisphosphonates.
Hornyák M; Hartmann JF; Sztaricskai FJ; Koncz A; Hernádi F
Acta Pharm Hung; 1999 Sep; 69(4):213-7. PubMed ID: 10544522
[TBL] [Abstract][Full Text] [Related]
12. A new semisynthetic macrolide antibiotic 3-O-oleandrosyl-5-O-desosaminylerythronolide A oxime.
LeMahieu RA; Ax HA; Blount JF; Carson M; Despreaux CW; Pruess DL; Scannell JP; Weiss F; Kierstead RW
J Antibiot (Tokyo); 1976 Jul; 29(7):729-34. PubMed ID: 783104
[TBL] [Abstract][Full Text] [Related]
13. Studies on anti-Helicobacter pylori agents. Part 1: Benzyloxyisoquinoline derivatives.
Yoshida Y; Barrett D; Azami H; Morinaga C; Matsumoto S; Matsumoto Y; Takasugi H
Bioorg Med Chem; 1999 Nov; 7(11):2647-66. PubMed ID: 10632076
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and antibacterial activities of novel 12-O-methylerythromycin A derivatives.
Ku YY; Riley D; Grieme T; Nilius A
J Antibiot (Tokyo); 1999 Oct; 52(10):908-12. PubMed ID: 10604761
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of 9-deoxo-4''-deoxy-6,9-epoxyerythromycin derivatives: novel and acid-stable motilides.
Faghih R; Lartey PA; Nellans HN; Seif L; Burnell-Curty C; Klein LL; Thomas P; Petersen A; Borre A; Pagano T; Kim KH; Heindel M; Bennani YL; Plattner JJ
J Med Chem; 1998 Aug; 41(18):3402-8. PubMed ID: 9719592
[TBL] [Abstract][Full Text] [Related]
16. 3-Keto-9-O-substituted oxime derivatives of 6-O-methyl erythromycin A synthesis and in vitro activity.
Shengxi C; Xiandong X; Lanxiang Y
J Antibiot (Tokyo); 2001 Jun; 54(6):506-9. PubMed ID: 11513040
[TBL] [Abstract][Full Text] [Related]
17. Helicobacter pylori resists arrest.
Owen RJ
Gut; 1999 Apr; 44(4):447-8. PubMed ID: 10075942
[No Abstract] [Full Text] [Related]
18. Studies on anti-Helicobacter pylori agents. Part 2: new cephem derivatives.
Yoshida Y; Matsuda K; Sasaki H; Matsumoto Y; Matsumoto S; Tawara S; Takasugi H
Bioorg Med Chem; 2000 Sep; 8(9):2317-35. PubMed ID: 11026544
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial activity and postantibiotic effect of flurithromycin against Helicobacter pylori strains.
Fera MT; Giannone M; Pallio S; Tortora A; Blandino G; Carbone M
Int J Antimicrob Agents; 2001 Feb; 17(2):151-4. PubMed ID: 11165121
[TBL] [Abstract][Full Text] [Related]
20. Anti-Helicobacter pylori agents. 3. 2-[(Arylalkyl)guanidino]-4-furylthiazoles.
Katsura Y; Nishino S; Ohno M; Sakane K; Matsumoto Y; Morinaga C; Ishikawa H; Takasugi H
J Med Chem; 1999 Jul; 42(15):2920-6. PubMed ID: 10425101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
